Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
ARIAD Pharmaceuticals, Inc.
ARIAD Reports First Quarter 2008 Financial Results
May 24th, 2008
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) reported financial results for the quarter ended March 31, 2008 and provided an update on corporate developments. "Since the beginning of the year, we have remained focused on our important corporate objectives: to maximize the deforolimus opportunity in multiple potential clinical indications; to establish our oncology commercial infrastructure; to advance our pipeline of innovative oncology product candidates; and to maintain a strong financial position," said Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD. "We are on track to achieve all of our key clinical development milestones this year for our two...
Source: Law & Health Weekly (2008-05-24)
|
